I was never a huge yogurt fan. And now with so much attention on gut health and fermented foods — especially fermented dairy — I decided to revisit my take on yogurt, with a focus on Greek yogurt.
My curiosity led me to Greek frozen yogurt, and I just may have evolved into a Greek froyo fan. The social media algorithm keeps putting Greek frozen yogurt food reviews before me. I am at a point where I can list the top 10 food influencer-endorsed Greek frozen yogurt spots in New York City. I have tried almost half of them.
Fermented foods and beverages are processed through controlled

Click here to read the Healio Exclusive, “Resurgence of measles spreads deep concern among ophthalmologists.”
Vitamin A administration in the context of measles is a complex issue that presents several challenges.
During my 30 years of working in children’s hospitals, I have had first-hand experience of how, despite decades of recommendations by the WHO and the American Academy of Pediatrics, vitamin A continues to be underutilized in the management of measles. As shown in a recent study in which I was personally involved, only about one-third of hospitalized children are treated and few with

PHOENIX — At-home devices for applying red light therapy to the eyes need further investigation as to their efficacy and safety, according to a speaker at Optometry’s Meeting.
“I can’t tell you the amount of at-home masks that have been popping up in my feed,” Cecelia Koetting, OD, MPH, FAAO, DipABO, assistant professor at University of Colorado Anschutz, said. “We don’t know if they’re safe, we don’t know if this is going to cause any problems, so I’m hesitant with them.”
Red light therapy is one of the most common applications

The American Society of Nephrology issued new kidney health guidance on cardiovascular-kidney-metabolic syndrome, highlighting the specific role of the kidneys in the disease’s treatment paradigm.
Nisha Bansal, MD, MS, professor of medicine and nephrology at the University of Washington School of Medicine, and Alexander R. Chang, MD, MS, professor in the departments of nephrology and population health sciences at Geisinger Medical Center, lead authors on the kidney health guidance, said the recommendations were developed to be “complementary rather than contradictory” to the recent American

Extensively drug-resistant Shigella has emerged in the United States over the past decade and a half — mostly among men.
According to a report published by the CDC that analyzed trends and epidemiologic characteristics associated with Shigella, the proportion of isolates that were characterized as extensively drug-resistant (XDR) increased from 0% in 2011 to 8.5% in 2023.
Historically, Shigella infections primarily occurred among children and were caused by strains that were susceptible to antibiotics, according to the report, which was authored by scientists at the CDC and seven state or city

During medical school, physicians spend years mastering anatomy, pathology and surgical technique, yet most of them receive little formal education in finance, investing, taxation or business management.
Despite this, physicians are routinely expected to make important decisions affecting hundreds of thousands — or even millions — of dollars over the course of their careers. Whether negotiating employment contracts, optimizing practice revenue, evaluating investment opportunities or preparing for retirement, it is not uncommon for doctors to gain firsthand knowledge on many of these pursuits

People who received B-cell depleting therapies after a recent MS diagnosis had slightly fewer relapses and a small reduction in lesions compared with people given oral treatments, according to research published in Neurology Open Access.
After 2 years, the type of treatment did not yield significant differences in disability scores or blood test results assessing nerve damage, Fredrik Piehl, PhD, professor of neurology at Karolinska Institutet, and colleagues wrote.
Patient characteristics differed based on the type of treatment they were receiving, indicating that patients were being selected

Our profession is appropriately energized by the remarkable pace of therapeutic advances across the spectrum of immune-mediated inflammatory diseases.
Targeted therapies, coupled with advances in basic and clinical immunology and rapidly evolving insights into the brain-immune axis, have transformed what we can offer our patients. Yet there may be an unintended consequence of this success. With such an extraordinary therapeutic armamentarium available — and even more on the horizon — we can become overly focused on suppressing inflammation as the answer to every patient who fails to meet the

MUNICH — Compared with anticoagulation alone, catheter-directed thrombolysis plus anticoagulation greatly reduced grave outcomes in patients with intermediate-high-risk acute pulmonary embolism, researchers reported.
For the PRAGUE-26 trial, presented at the European Society of Cardiology Congress and simultaneously published in The New England Journal of Medicine, researchers randomly assigned 558 patients (median age, 64 years; 40.9% women) with intermediate-high–risk acute pulmonary embolism (PE) to catheter-directed thrombolysis with alteplase plus anticoagulation or anticoagulation alone.

CagriSema conferred a greater weight reduction than tirzepatide for adults with type 2 diabetes, and induced weight loss of 21% at 68 weeks for those with overweight or obesity without diabetes, according to topline results from two trials.
Novo Nordisk announced data from the REIMAGINE 5 and REDEFINE 9 trials of different study populations. Both studies evaluated once-weekly injectable CagriSema, a fixed-dose combination of the amylin receptor agonist cagrilintide (Novo Nordisk) and GLP-1 receptor agonist semaglutide (Ozempic/Wegovy, Novo Nordisk).
The REIMAGINE 5 trial compared CagriSema 1